<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04895332</url>
  </required_header>
  <id_info>
    <org_study_id>BPOI</org_study_id>
    <nct_id>NCT04895332</nct_id>
  </id_info>
  <brief_title>BPOI (Berlin Pediatric Oxygenation Index) - A New Predictor for Imminent Failure of HFNC in Children Avoiding Delayed NIV or Intubation</brief_title>
  <official_title>BPOI (Berlin Pediatric Oxygenation Index) - A New Predictor for Imminent Failure of HFNC in Children Avoiding Delayed NIV or Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators developed an index that integrates different flow-settings in High-flow&#xD;
      nasal cannula (HFNC) therapy with non-invasively measured clinical parameters of oxygenation&#xD;
      in pediatric patients. This observational study is designed to evaluate this index and to&#xD;
      determine a cut-off value for imminent HFNC failure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High-flow nasal cannula therapy is a broadly used instrument of respiratory support in&#xD;
      pediatric and adult patients with respiratory failure.&#xD;
&#xD;
      For adult patients with pneumonia and respiratory failure, there is a validated index (ROX;&#xD;
      ratio SpO2/FiO2) which helps to identify those at risks for the need of intubation.&#xD;
&#xD;
      This index however is not applicable in the pediatric population because the physiological&#xD;
      values of respiratory rate vary greatly across different ages.&#xD;
&#xD;
      Thus, based on the particularities of pediatric patients the investigators developed an index&#xD;
      that integrates different flow-settings in HFNC therapy with non-invasively measured clinical&#xD;
      parameters of oxygenation. The BPOI is defined as the ratio of the product of the&#xD;
      peripherally measured oxygen saturation and the patient's body weight divided by the product&#xD;
      of HFNC flow and the fraction of inspired oxygen:&#xD;
&#xD;
      BPOI = (SpO2 * kg) / (Flow * FiO2)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>BPOI (Berlin Pediatric Oxygenation Index)</measure>
    <time_frame>01.01.2017-28.02.2021</time_frame>
    <description>Evaluation of a certain cut-off value for the BPOI (Berlin Pediatric Oxygenation Index) that predicts imminent failure of high-flow nasal cannula (HFNC) therapy in paediatric patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>01.01.2017-28.02.2021</time_frame>
    <description>Measurement of heart rate at given time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>01.01.2017-28.02.2021</time_frame>
    <description>Measurement of respiratory rate at given time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure (mean arterial pressure, MAP)</measure>
    <time_frame>01.01.2017-28.02.2021</time_frame>
    <description>Measurement of blood pressure at given time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit length of stay</measure>
    <time_frame>01.01.2017-28.02.2021</time_frame>
    <description>Time period until the patient is either deferred to another non-ICU or until end of treatment period/death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-flow nasal cannula therapy failure</measure>
    <time_frame>01.01.2017-28.02.2021</time_frame>
    <description>Count of days until the respiratory therapy is escalated to non-invasive ventilation after the cut-off value for the BPOI has been reached.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for intubation</measure>
    <time_frame>01.01.2017-28.02.2021</time_frame>
    <description>High-flow nasal cannula (HFNC) or non-invasively ventilation (NIV failure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for mechanical ventilation</measure>
    <time_frame>01.01.2017-28.02.2021</time_frame>
    <description>Need for assisted or controlled ventilation</description>
  </secondary_outcome>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Respiratory Failure (Pediatric Patients)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric Patients with respiratory failure and High-flow nasal cannula therapy (HFNC).&#xD;
&#xD;
        Approximately 220 patients will be enrolled in the observational study. Their data&#xD;
        collected during their entire hospital stay which is saved on the clinical data processing&#xD;
        system will be evaluated to reproduce the BPOI (BPOI = (SpO2 * kg) / (Flow * FiO2) ) We&#xD;
        will compare the indices of patients who failed and those who were successfully treated&#xD;
        with HFNC therapy. Failure is defined by the need for non-invasive or invasive mechanical&#xD;
        ventilation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with respiratory failure and indication für High-flow nasal cannula therapy&#xD;
&#xD;
          -  Patients aged between 4 1/7 weeks and 18 years&#xD;
&#xD;
          -  Patients who were treated between 01/01/2017 and 28/02/2021 in the Department of&#xD;
             Pediatric Pulmonology, Immunology and Intensive Care Medicine at Campus Virchow-&#xD;
             Klinikum, Charité - Universitätsmedizin Berlin&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients aged between 1 and 27 days (neonatal period)&#xD;
&#xD;
          -  Patients with congenital cyanotic heart defects&#xD;
&#xD;
          -  Patients after or in the course of haematopoetic stem cell transplantation&#xD;
&#xD;
          -  Patients with ambulatory respiratory support&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia Spies, MD, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claudia Spies, MD, Prof.</last_name>
    <phone>+49 30 450 55 11 02</phone>
    <email>claudia.spies@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Operative Intensive Care Medicine CCM and CVK,Charité - University Medicine Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Spies, MD Prof.</last_name>
      <phone>+4930450551001</phone>
      <email>claudia.spies@charite.de</email>
    </contact>
    <investigator>
      <last_name>David Grieser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Paediatrics with a focus on Pulmonology, Immunology and Intensive Care MedicineCharité - University Medicine Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Mall, MD, Prof.</last_name>
      <phone>+49 30 450 566131</phone>
      <email>marcus.mall@charite.de</email>
    </contact>
    <investigator>
      <last_name>Marcus Mall, MD, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Wiehlpütz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 17, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2021</study_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia Spies</investigator_full_name>
    <investigator_title>Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

